These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1354631

  • 1. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
    Okabe S, Narita M, Nakaji S, Takinami Y, Kawano O, Misaki N.
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
    [Abstract] [Full Text] [Related]

  • 2. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S, Takagi K, Igata H, Kato S, Shimosako K, Yamaji Y, Seiki M.
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [Abstract] [Full Text] [Related]

  • 3. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M, Ohba S, Ikarashi Y, Misaki N, Kawano O.
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [Abstract] [Full Text] [Related]

  • 4. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H, Hamada K, Taga F, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [Abstract] [Full Text] [Related]

  • 5. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
    Okabe S, Nishida T, Igata H, Takagi K.
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
    [Abstract] [Full Text] [Related]

  • 6. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
    Okabe S, Takeuchi K, Urushidani T, Takagi K.
    Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
    [Abstract] [Full Text] [Related]

  • 7. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M, Isobe Y, Arai I, Hirose-Kijima H, Usuki-Ito C, Nagai H, Aihara H, Otomo S.
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [Abstract] [Full Text] [Related]

  • 8. [Effects of Cuban analog (SWR-104SA), a new histamine H2 receptor antagonist, on gastric acid secretion and experimental ulcer formation].
    Shinkawa R, Kiso T, Kataoka H, Isoi T, Kakita T, Shogaki T, Ohtsubo Y.
    Yakugaku Zasshi; 1996 Oct; 116(10):783-91. PubMed ID: 8950870
    [Abstract] [Full Text] [Related]

  • 9. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
    Okabe S, Takeuchi K, Okada M, Kumadaki Y, Nakata M, Nakata H.
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M, Sakuma H, Shiratsuchi K, Mieda M.
    Arzneimittelforschung; 1985 Mar; 35(5):844-8. PubMed ID: 2862875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
    Okabe S, Kunimi H, Ohtsuki H.
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
    [Abstract] [Full Text] [Related]

  • 20. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.